Maybe mgt doesn't feel a need for a follow up PR at this
Maybe mgt doesn't feel a need for a follow up PR at this point as the results firmed up the remaining loose ends for a collaboration of some sort with a major BP?
With Dr Menon seeming to be backing off research a bit, it may be that Kevetrin is finally going to be able to be given the full treatment of increased trials and resources from a BP and testing with other cancer treatments in combo trials to make its mark in the world of cancer.
Must be a real tug of war for mgt in considering the pros and cons of doing it themselves or merging efforts with larger partners that bring so many further physical, human, and financial assets to the table.
Great to see another excellent poster come over here in Dauber, quite a valuable addition.
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
When Breakfast Gets a Fiery Makeover If you're craving breakfast with a side of heat, 7-Eleven's latest menu might just wake you up faster than a double espresso. Their newest collaboration with Cheetos Flamin' Hot is painting breakfast red at Laredo Taco Company, offering a lineup that's got tongues wagging and mouths watering. "After the response to our first Cheetos...
Continue Reading
O-I Glass Under Fire: The Glass Containers Giant Stumbles If you’ve been watching the ticker for O-I Glass, Inc. (NYSE:OI), you know it’s been a rocky road lately. We’re knee-deep in another saga of corporate promises meeting harsh reality. The novel here isn’t just the $1 trillion industry O-I Glass plays in, but the speed at which its fortunes seem to be...
Continue Reading
Chemours Under Fire: What’s Happening? Here we are, in the thick of a legal storm surrounding The Chemours Company. A class-action lawsuit is underway, and it’s painting the company in a rather unflattering light. Now, if you snagged some of that NYSE:CC action between February 20, 2026, and August 4, 2026, there's a chance you’re caught in the crossfire. Per the...
Continue Reading
Revving Up in Atlanta: SupplyHouse's Bold Move Folks, this isn’t just another blip on the logistical radar. SupplyHouse, a key player in the plumbing, HVAC, and electrical supply scene, is laying down roots in Atlanta. Yeah, just outside the bustling heart of the Southeast, they’re throwing up a fulfillment center as big as a small city block—715,000 square feet to...
Continue Reading
Appier's Stellar Q3 Performance: A Game Changer Well, ain't that a kicker? Out of the blue, Appier (TSE: 4180) has thrown down a Q3 performance that's got everyone talking. This AI-driven enterprise didn't just ride the wave of success—they created the tsunami. Strap in as we dive into what makes this quarter such a showstopper. Record-Breaking Numbers First off, let's...
Continue Reading
Streamlining Emergency Medical Procedures A seasoned paramedic from Norfolk, Virginia, with a knack for solving practical problems, has devised a tool that could revolutionize the emergency medical field: the Dual Purpose Intubation Blade. This innovation is not just about simplifying the intubation process; it’s about taking a massive step forward in how emergency...
Continue Reading
A Night of Recognition and Innovation Awaits Alright, folks, here's a story brewed from Michigan's manufacturing heartland. As the state gears up for the annual 2026 Manufacturing Excellence Awards, there's more being served up in Plymouth than just a fancy dinner and applause. CGI Digital and their posse at HelloNation are stepping into the fray, not just to clap...
Continue Reading
Something's Stirring in the Renewables Sector You ever feel like the renewable energy world is moving at a breakneck pace? Well, hold onto your hat because Exus Renewables North America just secured a hefty $345 million in financing led by Goldman Sachs Alternatives. It's got "big developments" written all over it, folks. What's the Deal Here? The funds are aimed squarely...
Continue Reading
Hit the Deck: Qfin's Legal Storm Brews When the suits begin to rumble, it’s high time to pull up a seat and watch how these chips fall. If you're parking your funds under NASDAQ:QFIN—heads up! A shareholder rights firm is bringing a class-action lawsuit, and investors perched between March 18 and August 25, 2026, should be ready to jump ship or fight. The Mighty...
Continue Reading
Latch's Performance: A Crunch Between Software and Setbacks The stock ticker might say "LTCH," but lately, Latch Inc. is feeling more like "OUCH" for investors. While they're trumpeting a solid 18% boost in software revenue, the numbers tell a mixed story. Yeah, their software side is singing, but hardware and services took a nosedive, dragging total revenue down 18.9%...
Continue Reading
Top 5 Most Recently Viewed Articles
Unlocking America’s Hidden Resources: A Path to Prosperity In today's economic landscape, a pressing topic arises as some resources remain largely overlooked. A recent presentation by a former CIA advisor has brought to light the potential of utilizing neglected federal resources to bolster the economy. This shift could play a crucial role in America's economic recovery...
Continue Reading
Celebrating Homegrown Talent with a Global Reach The Hong Kong Jockey Club, in collaboration with the renowned XIX Entertainment, announced a thrilling new chapter in the realm of global music by introducing Ariel Tsang as the first member of the pop group Now United from Hong Kong. This exciting development occurred during a media event at Tai Kwun, where Ariel made her...
Continue Reading
Silfab Solar Partners with Pivot Energy for Major Supply Deal Silfab Solar Inc., recognized for its leadership in the solar industry, has teamed up with Pivot Energy, a respected renewable energy provider. This collaboration marks a significant milestone as they announce a 350 megawatt (MW) supply agreement aimed at bolstering America's solar capacity and supporting...
Continue Reading
Pioneering Predictive Building Intelligence In the world of building management, size often dictates access to technology. Yet here comes Actuate, flipping the script and delivering cutting-edge, predictive building intelligence to operators who manage the unsung portfolios of small and mid-sized commercial properties. We're talking about the vast 80% of commercial...
Continue Reading
Investor Conference Participation by Design Therapeutics Design Therapeutics, Inc. (NASDAQ: DSGN), a pioneering biotechnology company based in Carlsbad, California, is preparing to take part in significant investor conferences. These events provide a platform for discussing their groundbreaking work in developing treatments aimed at serious degenerative genetic diseases....
Continue Reading